|
Clinical Outcome of Pharmaceutical Care for Smoking Cessation in Chatturat Hospital |
|---|---|
| รหัสดีโอไอ | |
| Creator | Panee Chaijandee |
| Title | Clinical Outcome of Pharmaceutical Care for Smoking Cessation in Chatturat Hospital |
| Contributor | Sunee Lertsinudom |
| Publisher | Faculty of Pharmaceutical Sciences KKU MSU UBU |
| Publication Year | 2559 |
| Journal Title | Isan Journal of Pharmaceutical Sciences |
| Journal Vol. | 12 |
| Journal No. | 3 |
| Page no. | 24-34 |
| Keyword | smoking cessation, pharmacist, hospital, clinical outcomes |
| URL Website | https://tci-thaijo.org/index.php/IJPS |
| Website title | Isan Journal ofPharmaceutical Sciences, IJPS |
| ISSN | 19050852 |
| Abstract | Smoking cessation can reduce morbidity and mortality due to the risk of smoking-related diseases.The objective of this study was to investigate on clinical outcome of pharmaceutical care for smoking cessation in Chatturat Hospital. Methods In a prospective, quasi experiment study, smokers were screened for willingness to quit smoking in Chatturat Hospital on September 2015 - March 2016. Data were collected during face-to-face and telephone counseling which continuingly following for a period of at least 6 months. The primary screenings included nicotine dependence and number of cigarettes smoked per day. Level of carbon monoxide (CO) in exhalation, percentage of peak expiratory flow rate (%PEFR) was measured at baseline in week 1, 2, 4, 8, 12 and 24 respectively. Results A total of 72 smokers were recruited in the study. All of these were men, the mean age was 47.38 years (SD=10.85). The result revealed that all subject smoked 20 cigarettes per day (SD=9.70) for 27.15 years (SD=10.15). At week 24, mean number of cigarettes per day was decreased significantly from baseline (from 20(SD=9.70) to 4(SD=6.33); p<0.001). Mean Fagerstrom scores were decreased significantly from baseline (from 6.00(SD=2.00) to 0.00(SD=1.58); p<0.001). At week 24, continuous abstinence rate was 43.06%. The similar declining was observed with CO (from 14.50(SD=9.11), 8(SD=12.45)ppm; p<0.001).Mean % PEFR was increased from 72.09(SD=16.86) to 82.24(SD=17.21); p<0.001. Number of smokers who had %PEFR less than 80% at baseline were significantly improved at the end of study (from 66.67% to 41.67%; p<0.001) and mean Framingham 10 - year risk scores significantly lower than baseline (from 16.80(SD=8.34) to 10.30(SD=5.12); p<0.05). Conclusions Pharmacists can provide stop smoking effectively. The smokers can quit smoking and lung function improves so pharmacists should be having the role with a multidisciplinary team to provide pharmaceutical care in smoking cessation in hospital. |
